Comparing doses of dialysis for severe kidney injury in ICU
Part of Kidney & urinary clinical trials.
This study tests different doses of a continuous blood-filtering treatment for critically ill patients with sudden kidney failure. It may help doctors find the best dose to improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have sudden kidney failure (acute kidney injury) that requires a special blood-filtering machine (continuous renal replacement therapy).
- You need strong medications (called vasopressors, like norepinephrine) to keep your blood pressure stable, at a dose above 0.1 mcg/kg/min.
- You or your family member must give written permission (informed consent) to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a type of continuous kidney dialysis, called CRRT, works in very sick patients in the intensive care unit. It may help doctors learn more about how to best care for people who need this treatment.
This study looks at how dialysis (renal replacement therapy) is used for patients in intensive care units (ICUs) with severe acute kidney injury in Latin America. Your participation can help improve care for people with kidney problems.
This study looks at how to safely remove excess fluid from patients in the ICU who have sudden kidney failure and are on a special blood-filtering machine (CRRT). Researchers want to understand which patients have trouble tolerating fluid removal and how to prevent complications.
This study compares two different doses of continuous kidney replacement therapy (CRRT, a type of dialysis) for patients in the intensive care unit with acute kidney injury. It aims to find out if a lower dose is as safe and effective as the standard dose.
This study compares two intensities (low vs. medium) of continuous dialysis for people with sudden kidney failure in the ICU. It aims to find which level of treatment works best for critically ill patients.
This trial compares a lower dose versus a standard dose of continuous kidney replacement therapy (CRRT) for critically ill patients with acute kidney injury (AKI — sudden kidney failure). It aims to see if lower doses are safe and effective.
Hear when a new Renal Replacement Therapy for Acute Kidney Injury in ICU trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.